Hun-Sik Wang
Chief Executive Officer at GL PHARM TECH CORP.
Net worth: 1 M $ as of 31/03/2024
Profile
Hun-Sik Wang is currently the Chief Executive Officer and Director at GL Pharm Tech Corp.
Prior to this, he was the Chief Executive Officer at GL PharmTech, Inc. and Co-Chief Executive Officer at Crown Pharm Co., Ltd.
He holds a doctorate degree from Chungnam National University and a graduate degree from Chung-Ang University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GL PHARM TECH CORP.
1.30% | 06/03/2024 | 993,323 ( 1.30% ) | 1 M $ | 31/03/2024 |
Hun-Sik Wang active positions
| Companies | Position | Start |
|---|---|---|
| GL PHARM TECH CORP. | Chief Executive Officer | 01/08/2002 |
Former positions of Hun-Sik Wang
| Companies | Position | End |
|---|---|---|
Crown Pharm Co., Ltd.
 Crown Pharm Co., Ltd. Pharmaceuticals: OtherHealth Technology Crown Pharm Co., Ltd. manufactures medicine and other related products. Its products include Sexcon, Haisoming A, Ganeca, Denti F, Traming, entas, Smer, Alpina, Muspan, Mg-pherol, Picolax, Glutase, and Cragel. The company was founded on February 9, 1985 and is headquartered in Anyang, South Korea. | Chief Executive Officer | - |
GL PharmTech, Inc. /Old/
 GL PharmTech, Inc. /Old/ Pharmaceuticals: MajorHealth Technology GL PharmTech, Inc. develops and manufactures new drugs and pharmaceuticals. Its products include incrementally modified and generic drugs and Artemisia leaf extract tablets. The company was founded in August 2002 and is headquartered in Seongnam, South Korea. | Chief Executive Officer | - |
Training of Hun-Sik Wang
| Chungnam National University | Doctorate Degree |
| Chung-Ang University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
GL PharmTech, Inc. /Old/
GL PharmTech, Inc. /Old/ Pharmaceuticals: MajorHealth Technology GL PharmTech, Inc. develops and manufactures new drugs and pharmaceuticals. Its products include incrementally modified and generic drugs and Artemisia leaf extract tablets. The company was founded in August 2002 and is headquartered in Seongnam, South Korea. | Health Technology |
| GL Pharm Tech Corp. | |
Crown Pharm Co., Ltd.
Crown Pharm Co., Ltd. Pharmaceuticals: OtherHealth Technology Crown Pharm Co., Ltd. manufactures medicine and other related products. Its products include Sexcon, Haisoming A, Ganeca, Denti F, Traming, entas, Smer, Alpina, Muspan, Mg-pherol, Picolax, Glutase, and Cragel. The company was founded on February 9, 1985 and is headquartered in Anyang, South Korea. | Health Technology |
- Stock Market
- Insiders
- Hun-Sik Wang
